Home Companies ExThera Medical COMPANY
2 open jobs · last seen Oct 23, 2026 · 6 sources
Profile checked Oct 10, 2026
Keywords: Long COVID COVID-19 Pancreatic Ductal Adenocarcinoma (mPDAC) Metastatic Colorectal Carcinoma Septic Shock Pancreatic Ductal Adenocarcinoma Bacteremia Bacterial Infection ONCObind (Onco-Seraph) 100 Filter Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) Seraph 100 Seraph 100 Filter Show all 12 keywords
At a glance HQ Martinez, CA source Latest trial Not phased (device or behavioral study): OSCAR II STUDY - The ONCObind CTC Removal Study (Jan 15, 2027) source Timeline Jan 15, 2027 Trial start Not phased (device or behavioral study): OSCAR II STUDY - The ONCObind CTC Removal Study source ↗ Feb 15, 2025 Trial start Not phased (device or behavioral study): Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC) source ↗ Aug 29, 2024 Trial start Not phased (device or behavioral study): OSCAR I STUDY - The ONCObind CTC Removal Study source ↗ Apr 19, 2024 Trial start Not phased (device or behavioral study): Blood Purification for the Treatment of Pathogen Associated Shock source ↗ May 4, 2021 Trial start Not phased (device or behavioral study): Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 source ↗ 2016-02 Trial start Not phased (device or behavioral study): Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis source ↗ Upcoming milestones Dec 31, 2026 (ESTIMATED) · Not phased · Blood Purification for the Treatment of Pathogen Associated Shock · NCT05011656 Jan 31, 2027 (ESTIMATED) · Not phased · Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 · NCT04547257 Jun 1, 2027 (ESTIMATED) · Not phased · OSCAR II STUDY - The ONCObind CTC Removal Study · NCT06655142 Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 6 Record Title Phase Status Start Primary completion NCT06637800 Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC) Not phased (device or behavioral study) Withdrawn Feb 15, 2025 2025-04 (estimated) NCT04547257 Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 Not phased (device or behavioral study) Active, not recruiting May 4, 2021 Jan 31, 2027 (estimated) NCT06655142 OSCAR II STUDY - The ONCObind CTC Removal Study Not phased (device or behavioral study) Not yet recruiting Jan 15, 2027 Jun 1, 2027 (estimated) NCT05011656 Blood Purification for the Treatment of Pathogen Associated Shock Not phased (device or behavioral study) Active, not recruiting Apr 19, 2024 Dec 31, 2026 (estimated) NCT06481397 OSCAR I STUDY - The ONCObind CTC Removal Study Not phased (device or behavioral study) Completed Aug 29, 2024 Sep 21, 2024 (actual) NCT02914132 Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis Not phased (device or behavioral study) Completed 2016-02 Jun 7, 2018 (actual)
Open jobs 2 Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Connect See your connections at ExThera Medical on LinkedIn (search by name, results not checked) LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-18
